Healthcare Sales & Marketing Network News: infertility

Searching News Database: infertility

HSMN NewsFeed - 18 Oct 2022
FDA Approves First IND of its Kind for Allogenic Exosomal Treatment of Female Reproductive Disorder - Primary Ovarian Insufficiency
Biopharmaceuticals FDA

HSMN NewsFeed - 4 May 2022
Abbott Obtains FDA Clearance for First Test that Simultaneously Detects Four Common Sexually Transmitted Infections (STIs) as Cases are on the Rise
Diagnostics FDA

HSMN NewsFeed - 30 Aug 2021
Visby Medical(TM) Receives FDA Clearance and CLIA Waiver at the Point of Care for PCR Sexual Health Test
Diagnostics FDA

HSMN NewsFeed - 1 Sep 2020
MedGyn Completes Acquisition of Thomas Medical
Devices Mergers & Acquisitions

HSMN NewsFeed - 14 Aug 2020
Lupin Presents Phase 3 Data for Solosec(R) (secnidazole) Demonstrating Significant Response Rate in Female Patients with Trichomoniasis
Biopharmaceuticals

HSMN NewsFeed - 11 Mar 2020
INVOcell Appoints Yve Lyppens as Director Business Development Asia Pacific
Devices Personnel

HSMN NewsFeed - 13 Feb 2020
INVO Bioscience Announces Appointment of Inger Britt Carlsson as VP of Medical Affairs
Devices Personnel

HSMN NewsFeed - 10 Feb 2020
Enteris BioPharma Appoints Gary A. Shangold, MD, as Chief Medical Officer
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 8 Jan 2020
Aruvant Receives FDA Rare Pediatric Disease Designation for ARU-1801 for the Treatment of Sickle Cell Disease
Biopharmaceuticals FDA

HSMN NewsFeed - 12 Aug 2019
binx health Receives FDA 510(k) Clearance For Rapid Point Of Care Platform For Women's Health
Diagnostics FDA

HSMN NewsFeed - 14 Jan 2019
INVO Bioscience Closes Exclusive U.S. Licensing Agreement with Ferring Pharmaceuticals to Commercialize the Novel INVOcell(TM) System for Use in the Treatment of Infertility
Biopharmaceuticals Licensing

HSMN NewsFeed - 16 Oct 2018
FDA Approves Medicines360's sNDA for LILETTA(R) (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Five Years
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 31 Aug 2018
Rehan Verjee to Lead EMD Serono as Company Advances its Innovative Medicines Strategy in North America
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 May 2018
Egalet Announces Large Regional Plan to Cover SPRIX(R) Nasal Spray
Biopharmaceuticals Reimbursement

HSMN NewsFeed - 16 Apr 2018
Roche receives FDA clearance for cobas(R) CT/NG for cobas(R) 6800/8800 Systems
Diagnostics FDA

HSMN NewsFeed - 15 Mar 2018
DxNow, Inc. Receives FDA 510(k) Clearance for ZyMōt(TM) ICSI and ZyMōt(TM) Multi Sperm Separation Devices
Devices FDA

HSMN NewsFeed - 18 Dec 2017
Aytu BioScience Announces Appointment of David Green as Chief Financial Officer
Biopharmaceuticals Urology Personnel

HSMN NewsFeed - 13 Nov 2017
EMD Serono Receives FDA Approval for New GONAL-f(R) RFF Redi-ject(R) Pen
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 26 Oct 2017
Aytu BioScience Provides Quarterly Update on the Natesto(R) U.S. Launch
Biopharmaceuticals Drug Delivery Product Launch

HSMN NewsFeed - 3 Oct 2017
Aytu BioScience Announces International Distribution Agreement for Fiera(R) in Japan
Biopharmaceuticals Urology Distribution

HSMN NewsFeed - 7 Aug 2017
FDA Approves Medicines360's sNDA for LILETTA(R) (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Four Years
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 7 Aug 2017
Impax Announces Settlement of Contract Litigation on Opana(R) ER (Oxymorphone Hydrochloride) CII Extended-Release Tablets
Biopharmaceuticals Litigation

HSMN NewsFeed - 13 Jul 2017
Aytu BioScience Expands MiOXSYS(R) Distribution Network with a Fertility-Focused Company in Over 20 Countries in Europe
Diagnostics Urology Distribution

HSMN NewsFeed - 24 Mar 2017
Surgery Without the Knife: Mirabilis Medical Announces European Approval for Non-Invasive Uterine Fibroid Treatment
Devices Regulatory

HSMN NewsFeed - 22 Feb 2017
Symbiomix Therapeutics Appoints David L. Stern as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Jan 2017
Myovant Sciences Initiates Phase 3 Clinical Program of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Biopharmaceuticals

HSMN NewsFeed - 16 Nov 2016
Myovant Sciences Appoints Terrie Curran to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Nov 2016
Boston Scientific Acquires Resectr(TM) Tissue Resection Device from Distal Access, LLC
Devices Surgery Acquisitions

HSMN NewsFeed - 14 Sep 2016
European Commission Approves CABOMETYX(TM) (cabozantinib) Tablets for the Treatment of Advanced Renal Cell Carcinoma Following VEGF-Targeted Therapy
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 9 May 2016
Allergan and Richter Announce Positive Phase III Results for Ulipristal Acetate 5 and 10 mg in the Treatment of Uterine Fibroids
Biopharmaceuticals

HSMN NewsFeed - 3 Mar 2016
Allergan Launches Bold Access To LILETTA(R) (levonorgestrel-releasing intrauterine system)
Biopharmaceuticals Drug Delivery Product Launch

HSMN NewsFeed - 9 Feb 2016
Aytu BioScience Announces First Commercial Sales for Company's MiOXSYS(TM) System for Male Infertility
Devices Urology Product Launch

HSMN NewsFeed - 12 Jan 2016
Aytu BioScience Obtains CE Marking for Company's MiOXSYS(TM) System for Male Infertility
Biopharmaceuticals Urology Regulatory

HSMN NewsFeed - 23 Nov 2015
ObsEva Closes CHF 60 (USD 60) Million in Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 29 Jul 2015
Corvida Medical Receives FDA 510(k) Clearance for Halo(TM) Closed System Transfer Device
Devices FDA

HSMN NewsFeed - 29 Jun 2015
Aerie Pharmaceuticals Elects Julie McHugh and Michael M. du Toit to the Company’s Board of Directors
Biopharmaceuticals Ophthalmology Personnel

HSMN NewsFeed - 13 Apr 2015
Actavis and Medicines360 Announce U.S. Availability of LILETTA(TM) (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Three Years
Biopharmaceuticals Product Launch

HSMN NewsFeed - 9 Dec 2014
Zydus Launches World's First Biosimilar of Adalimumab
Biopharmaceuticals Product Launch

HSMN NewsFeed - 17 Nov 2014
First U.S. Procedures Completed With The Symphion(TM) Hysteroscopic Tissue Removal System
Devices Product Launch

HSMN NewsFeed - 28 Jul 2014
New Chlamydia and Gonorrhea Assays on the BD Viper(TM) LT System Receive FDA 510k Clearance
Diagnostics FDA

HSMN NewsFeed - 10 Jun 2014
Auxogyn Receives FDA Clearance for Its Eeva(TM) System
Devices FDA

HSMN NewsFeed - 17 Apr 2014
Nora Therapeutics Announces $18 Million Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 7 Apr 2014
Merck Serono Announces Initiation of Phase III START2 Study with Tecemotide in Stage III Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 31 Mar 2014
New Global Initiative Aims to Improve Patient Outcomes in Metastatic Colorectal Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 27 Mar 2014
Merck Announces Initiation of Phase III Fertility Study with Pergoveris in Poor Ovarian Response Patients
Biopharmaceuticals

HSMN NewsFeed - 7 Feb 2014
Ipsen announces positive top line results from phase III clinical study of Decapeptyl(R) (triptorelin pamoate) 11.25 mg administered subcutaneously in patients with prostate cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 13 Jan 2014
OvaScience Provides Update on Pipeline Advancements and Commercial Plans; New Potential Fertility Treatment OvaPrime(SM) to Launch in 2015
Biopharmaceuticals

HSMN NewsFeed - 10 Jan 2014
OvaScience Announces Global Healthcare Strategist Marc Kozin Joins Company’s Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Jan 2014
OvaScience Appoints David Stern to Executive Vice President, Global Commercial Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Dec 2013
European Commission Approves Update of Erbitux Metastatic Colorectal Cancer Labeling to Patients With RAS Wild-Type Tumors
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 16 Dec 2013
EMD Serono's Redesigned Fertility Pen Available for Distribution in US
Biopharmaceuticals Drug Delivery Product Launch

HSMN NewsFeed - 29 Aug 2013
ObsEva SA Announces CHF 32 Million Series A Funding From Leading Venture Capital Firms and a License Agreement With Merck Serono
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 26 Jun 2013
Pluristem Enters Into Strategic Partnership and Licensing Agreement With Cha Bio&Diostech for the Development and Commercialization of PLX Cells for the Treatment of CLI and IC in South Korea
Regenerative Medicine Licensing

HSMN NewsFeed - 28 Feb 2013
Auxogyn Appoints Women's Health Leader, Kathryn A. Tunstall, to Board of Directors
Diagnostics Personnel

HSMN NewsFeed - 5 Feb 2013
Merck Serono and Opexa Therapeutics Enter into Option and License Agreement for Development of Tcelna(TM) (imilecleucel-T) for Treatment of Multiple Sclerosis
Biopharmaceuticals Neurology Licensing

HSMN NewsFeed - 28 Jan 2013
New NCCN Guidelines for Patients(R) Available for Adolescents and Young Adults with Cancer
Biopharmaceuticals Devices Oncology

HSMN NewsFeed - 23 Jan 2013
Watson Acquires Uteron Pharma SA
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 14 Jan 2013
Hologic Announces FDA Clearance of APTIMA Trichomonas for Use on PANTHER System
Diagnostics FDA

HSMN NewsFeed - 29 Jun 2012
Biogen Idec and Isis Pharmaceuticals Announce Global Collaboration for Antisense Program Targeting Myotonic Dystrophy
Biopharmaceuticals

HSMN NewsFeed - 6 Jun 2012
TRUCLEAR(TM) 5.0 System offers US surgeons a patient-friendly option for removing intrauterine polyps in office or clinical setting
Devices FDA

HSMN NewsFeed - 5 Jun 2012
Abbott Announces Initiation of Phase 3 Study of Elagolix in Patients with Endometriosis
Biopharmaceuticals

HSMN NewsFeed - 4 Apr 2012
OvaScience Secures $37 Million in Series B Financing
Regenerative Medicine Venture Capital Personnel

HSMN NewsFeed - 27 Feb 2012
European Commission Approves Esmya(R) for the Pre-Operative Treatment of Uterine Fibroids (myomas)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 3 Feb 2012
Threshold Pharmaceuticals and Merck KGaA Announce Global Agreement to Co-Develop and Commercialize Phase 3 Hypoxia-Targeted Drug TH-302
Biopharmaceuticals Oncology

HSMN NewsFeed - 15 Nov 2011
Innocoll Enters Partnership with Merus Labs in Canada for the Distribution of CollaGUARD
Devices Distribution

HSMN NewsFeed - 11 Oct 2011
Innocoll Announces European Approval for CollaGUARD(R), Surgical Adhesion Barrier
Devices Surgery Regulatory

HSMN NewsFeed - 6 Apr 2011
Smith & Nephew's TRUCLEAR System: A Gold Standard for Removal of Intrauterine Polyps and Fibroids
Devices Litigation

HSMN NewsFeed - 7 Jan 2011
Hologic Acquires Interlace Medical
Devices Surgery Mergers & Acquisitions

HSMN NewsFeed - 16 Dec 2010
Watson and Richter Announce Exclusive License Agreement for Esmya
Biopharmaceuticals Licensing

HSMN NewsFeed - 29 Sep 2010
InSightec Launches ExAblate(R) One and ExAblate(R) OR Systems at CIRSE 2010
Devices Surgery

HSMN NewsFeed - 13 Sep 2010
LabCorp Enters into Definitive Agreement to Acquire Genzyme Genetics
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 13 Aug 2010
Watson Plans Q4 2010 ella(R) (ulipristal acetate) Emergency Contraceptive Launch
Biopharmaceuticals FDA

HSMN NewsFeed - 16 Jun 2010
Abbott and Neurocrine Announce Global Agreement to Develop and Commercialize Elagolix for the Treatment of Endometriosis
Biopharmaceuticals

HSMN NewsFeed - 10 May 2010
Ferring Acquires LYSTEDA(TM) From Xanodyne Pharmaceuticals, Inc.
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 22 Apr 2010
Novartis Receives US FDA Approval for Zortress(R) (everolimus) to Prevent Organ Rejection in Adult Kidney Transplant Recipients
Biopharmaceuticals FDA

HSMN NewsFeed - 29 Mar 2010
Merck Serono: Erbitux Granted Extended Use in Japan for 1st-Line Treatment of mCRC Patients with KRAS Wild-Type Tumors
Biopharmaceuticals Oncology

HSMN NewsFeed - 4 Mar 2010
Watson Announces Agreement to Acquire U.S. Rights to Columbia Laboratories' CRINONE(R) Progesterone Gel Product Line
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 4 Feb 2010
Launch of Ipsen's Decapeptyl(R) 6-Month Formulation (LP 22.5 mg) in France for the Treatment of Locally Advanced or Metastatic Hormone-Dependent Prostate Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 28 Jan 2010
Merck Receives European Approval for ELONVA(R) (corifollitropin alfa injection), a New Fertility Treatment
Biopharmaceuticals Regulatory

HSMN NewsFeed - 4 Dec 2009
Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial
Biopharmaceuticals Oncology

HSMN NewsFeed - 14 Oct 2009
Timm Medical Technologies and Ferring Pharmaceuticals Enter Exclusive Co-Promotion Agreement for Prosed(R) DS
Biopharmaceuticals Urology

HSMN NewsFeed - 4 Aug 2009
Ferring Pharmaceuticals Announces Trade Name FIRMAGON(R) (degarelix for injection) for Advanced Prostate Cancer Treatment
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 1 Jun 2009
UK's NICE Recommends Use of Erbitux for Metastatic Colorectal Cancer Patients
Biopharmaceuticals Oncology

HSMN NewsFeed - 13 May 2009
Ferring Pharmaceuticals Unveils Six-Month Efficacy Data for EUFLEXXA(R) for the Treatment of Osteoarthritis Knee Pain
Biopharmaceuticals

HSMN NewsFeed - 11 May 2009
Debiopharm and Mepha Sign Distribution Agreement for Pamorelin(R) LA
Biopharmaceuticals Oncology Distribution

HSMN NewsFeed - 7 May 2009
Merck Serono Initiates SETTLE, the Second Phase III Clinical Trial of Safinamide in Advanced Parkinson's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 5 May 2009
Merck Serono Launches Glucophage Powder in First European Countries
Biopharmaceuticals Endocrinology Regulatory

HSMN NewsFeed - 21 Apr 2009
Merck Serono Launches Kuvan(R) in Europe
Biopharmaceuticals

HSMN NewsFeed - 7 Apr 2009
FDA Approves Label Change for Non-Invasive Fibroid Treatment
Devices FDA

HSMN NewsFeed - 23 Mar 2009
Merck Serono Launches Strategic Venture Capital Fund
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 4 Mar 2009
Ferring Pharmaceuticals Announces Immediate Availability of Degarelix for the Treatment of Advanced Prostate Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 24 Feb 2009
Merck Serono and Ambrx Expand Collaboration Through ARX424 Multiple Sclerosis Drug Development Alliance
Biopharmaceuticals Neurology

HSMN NewsFeed - 19 Feb 2009
European Medicines Agency Recommends Suspension of Marketing Authorization for Raptiva(R)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 3 Feb 2009
Merck Serono's Safinamide Significantly Improved Motor Function in Patients With Advanced Parkinson's Disease in a Phase III Pivotal Trial
Biopharmaceuticals Neurology

HSMN NewsFeed - 23 Jan 2009
Merck Serono's Oral Investigational Treatment Cladribine Tablets for Multiple Sclerosis Significantly Reduced Relapse Rate in Two-Year Phase III Pivotal Trial
Biopharmaceuticals Neurology

HSMN NewsFeed - 13 Jan 2009
Merck Serono and Apitope Announce Licensing Agreement on Novel Peptide Therapeutics for the Treatment of Multiple Sclerosis
Biopharmaceuticals Neurology

HSMN NewsFeed - 9 Dec 2008
Merck Serono's Kuvan(R) Receives Marketing Authorization in Europe
Biopharmaceuticals Regulatory

HSMN NewsFeed - 12 Nov 2008
Ferring Pharmaceuticals Promotes William Garbarini to Vice President of New Orthopaedics and Urology Business Unit
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Oct 2008
Sosei Agrees Terms With ASKA for Commercialisation of SOH-075 (NorLevo(R))
Biopharmaceuticals

HSMN NewsFeed - 2 Oct 2008
Covidien Introduces the SprayShield(TM) Adhesion Barrier System to the European Marketplace
Devices Surgery

HSMN NewsFeed - 26 Sep 2008
Merck Serono's Kuvan(R) Recommended for European Approval
Biopharmaceuticals Regulatory

HSMN NewsFeed - 23 Sep 2008
Vyteris Announces Growth Initiative Through Expanded Business Development Team
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 22 Sep 2008
Results From IMPROVE Study Show Therapeutic Effect of New Formulation of Rebif(R) at 16 Weeks in Patients With Multiple Sclerosis
Biopharmaceuticals Neurology

HSMN NewsFeed - 10 Sep 2008
Dr. Paul Korner Joins Ferring Pharmaceuticals as Vice President, Medical Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Jul 2008
Cochlear Announces Milestone in Hearing Restoration With 120,000 Nucleus(R) Cochlear Implants
Devices

HSMN NewsFeed - 13 Jun 2008
New Roche Chlamydia Test Approved for Use in European Union
Diagnostics Regulatory

HSMN NewsFeed - 10 Jun 2008
Merck Serono Strengthens its Prescription Medicines Portfolio in Latin America
Biopharmaceuticals Distribution

HSMN NewsFeed - 10 Jun 2008
Merck Serono's Rebif(R) Celebrates 10th Anniversary
BIopharmaceuticals Neurology

HSMN NewsFeed - 5 Jun 2008
Merck Serono Announces Initiation of Second Phase II/III Clinical Study of Atacicept in Lupus
Biopharmaceuticals

HSMN NewsFeed - 5 May 2008
Unique Three-Year Data Demonstrating Long-Term Efficacy and Safety of Raptiva(R) in the Treatment of Psoriasis Published in the British Journal of Dermatology
Biopharmaceuticals

HSMN NewsFeed - 29 Apr 2008
Mirabilis Completes First Human Trial of Non-Invasive Treatment for Uterine Fibroids
Devices

HSMN NewsFeed - 16 Apr 2008
Merck Announces Planned Investment of $50 Million in Research Center in the US
Biopharmaceuticals

HSMN NewsFeed - 15 Apr 2008
BioSante Pharmaceuticals Appoints Michael C. Snabes, M.D., PhD, Vice President, Clinical Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Mar 2008
Merck Serono Launches Cyanokit(R) in Japan
Biopharmaceuticals

HSMN NewsFeed - 12 Feb 2008
Ipsen: Clinical Update For Decapeptyl(R) 6-Month Formulation in Advanced Prostate Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 29 Jan 2008
Duska Therapeutics Completes Corporate Office Relocation to La Jolla
Biopharmaceuticals

HSMN NewsFeed - 23 Jan 2008
Molecular Biometrics Hires Denny Sakkas, PhD Renowned Yale Embryologist and International Thought-Leader, as Chief Scientific Officer; Opening U.S. Research Facility
Diagnostics Personnel

HSMN NewsFeed - 4 Dec 2007
PregLem SA Announces CHF 36 Million Series B Funding and New Licencing Agreement With HRA Pharma
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 27 Nov 2007
Cook Medical Delivers Innovative Treatment for Recto-Vaginal Fistulas
Devices

HSMN NewsFeed - 7 Nov 2007
Cost-Effectiveness Study Supports Use of EUFLEXXA(TM) by Rheumatologists for Pain Relief in Patients with Knee Osteoarthritis
Biopharmaceuticals

HSMN NewsFeed - 6 Nov 2007
Direct Medical Systems Introduces the Smallest and Lightest Ultrasound System in the World That Will Replace the 200-Year-Old Stethoscope
Devices

HSMN NewsFeed - 31 Oct 2007
Duska Therapeutics Appoints Dr. Alan J. Tuchman to the Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Oct 2007
QuantRx Biomedical Corporation Announces FDA 510(k) Clearance for Its Follicle Stimulating Hormone (FSH) Immunoassay Test
Diagnostics FDA

HSMN NewsFeed - 22 Oct 2007
First-in-Man Single Port Pediatric Urological Operations Performed at Cleveland Clinic
Devices Surgery

HSMN NewsFeed - 18 Oct 2007
Duska Therapeutics Appoints Shepard Goldberg and Steven Dinh as Board Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Oct 2007
Duska Therapeutics Appoints H. David Coherd to the Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Oct 2007
Duska Therapeutics Names Dr. James S. Kuo as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Sep 2007
Columbia Laboratories Signs U.S. License and Supply Agreement with Ascend Therapeutics to Market PROCHIEVE(R) 4% Progesterone Gel
Biopharmaceuticals Licensing

HSMN NewsFeed - 10 Sep 2007
Aspreva Provides Update On Lupus Nephritis Development Program
Biopharmaceuticals

HSMN NewsFeed - 22 Aug 2007
Bariatric Surgical Society Takes on New Name, New Mission and New Surgery
Surgery Endocrinology

HSMN NewsFeed - 22 Aug 2007
ViaCell Expands Study Sites in ViaCyte Pivotal Trial
Regenerative Medicine

HSMN NewsFeed - 17 Jul 2007
Repromedix Appoints Dr. Michael J. Burns Chief Executive Officer
Diagnostics Personnel

HSMN NewsFeed - 27 Jun 2007
Aspreva and Roche announce preliminary results for phase III study evaluating CellCept in lupus nephritis
Biopharmaceuticals

HSMN NewsFeed - 26 Jun 2007
Cook Medical Introduces Device to Naturally Prepare Pregnant Women for Labor Induction
Devices

HSMN NewsFeed - 21 Jun 2007
FDA Approves Ferring Pharmaceuticals' ENDOMETRIN(R) for Luteal Phase Support in Assisted Reproductive Technology Treatment
Biopharmaceuticals FDA

HSMN NewsFeed - 31 May 2007
Halozyme Therapeutics Announces Closing of $32.1 Million Private Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 16 May 2007
Halozyme Therapeutics Names Randal J. Kirk and Kathryn E. Falberg to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 May 2007
Hamilton Thorne Biosciences Announces Third-round FDA Marketing Clearance of its ZILOS-tk(R) Zona Laser Drill for Additional Clinical Applications of Blastomere Biopsy and Trophectoderm Biopsy
Devices FDA

HSMN NewsFeed - 14 May 2007
InSightec Encourages Uterine Fibroid Sufferers to Ask Their Doctors About Less Invasive Treatment Options
Devices

HSMN NewsFeed - 8 May 2007
AEterna Zentaris Regains Exclusive Worldwide (ex-Japan) Rights from Solvay for Cetrorelix in Endometriosis Indication
Biopharmaceuticals

HSMN NewsFeed - 7 May 2007
Early Results of the CellCept(R) Spare the Nephron Study Examine Kidney Function
Biopharmaceuticals

HSMN NewsFeed - 1 May 2007
OTN and Oncology Molecular Imaging Enter Into Exclusive Strategic Alliance Agreement to Offer Diagnostic Imaging and Radiation Therapy Services to Community-Based Oncologists
Devices Radiology Oncology

HSMN NewsFeed - 20 Mar 2007
ViaCell Announces Commencement of ViaCyte Pivotal Trial
Regenerative Medicine

HSMN NewsFeed - 15 Mar 2007
Vitrolife: New Vice President Marketing & Sales
Devices Personnel

HSMN NewsFeed - 12 Mar 2007
Cangene receives an approvable letter from the FDA for human growth hormone
Biopharmaceuticals FDA

HSMN NewsFeed - 12 Mar 2007
InSightec's ExAblate(R) 2000 Magnetic Resonance-Guided Focused Ultrasound (MRgFUS) System is Approved for Sale in Canada
Devices Regulatory

HSMN NewsFeed - 12 Mar 2007
Schering-Plough to Acquire Organon BioSciences
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 5 Mar 2007
Elbit Medical Group Announces FDA Approval of New Version of InSightec's ExAblate(R) 2000 That Speeds Up Treatment Time and the Use of ExAblate 2000 System With GE Healthcare's 3 Tesla Magnetic Resonance Imaging System
Devices FDA

HSMN NewsFeed - 1 Mar 2007
FDA Approves use of InSightec's ExAblate(R) 2000 With GE Healthcare's 3 Tesla Magnetic Resonance Imaging System
Devices FDA

HSMN NewsFeed - 1 Mar 2007
FDA Approves New Version of InSightec's ExAblate(R) 2000 That Speeds up Treatment Time
Devices FDA

HSMN NewsFeed - 20 Feb 2007
Bakri Postpartum Balloon Globally Acknowledged for Treatment of Postpartum Bleeding
Devices

HSMN NewsFeed - 20 Feb 2007
Vyteris Announces Senior Staff Promotions
Devices Drug Delivery Personnel

HSMN NewsFeed - 14 Feb 2007
Halozyme Therapeutics and Baxter Present Promising Results for the Use of HYLENEX From the Infuse-Morphine Study
Biopharmaceuticals

HSMN NewsFeed - 14 Feb 2007
Halozyme and Baxter Expand Global HYLENEX Collaboration
Biopharmaceuticals

HSMN NewsFeed - 4 Feb 2007
Phase III Trial of Progesterone for the Prevention of Preterm Birth in Women with a Previous Preterm Birth Earlier than 35 Weeks Does Not Meet Endpoints
Biopharmaceuticals

HSMN NewsFeed - 31 Jan 2007
Adeza Receives Orphan Drug Designation for Gestiva
Biopharmaceuticals FDA

HSMN NewsFeed - 14 Dec 2006
Nonsurgical Treatment for Arteriovenous Malformations
Devices Interventional Neurology Radiology

HSMN NewsFeed - 5 Dec 2006
Halozyme and Roche Enter Agreement for the Application of Enhanze, A Novel Technology to Improve Drug Delivery
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 16 Nov 2006
Comprehensive Review Published on FzioMed Technology for Postsurgical Adhesion Prevention
Devices Surgery

HSMN NewsFeed - 8 Nov 2006
Halozyme Therapeutics Names William Fallon Vice President, Manufacturing & Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Oct 2006
Aspreva Pharmaceuticals Announces Preliminary Results of Phase III Trial of CellCept for Myasthenia Gravis
Biopharmaceuticals

HSMN NewsFeed - 23 Oct 2006
Adeza Receives FDA Approvable Letter for Gestiva
Biopharmaceuticals FDA

HSMN NewsFeed - 18 Oct 2006
Gen-Probe Receives FDA Clearance to Run Standalone APTIMA(R) Tests for Chlamydia and Gonorrhea on the TIGRIS(R) System
Diagnostics FDA

HSMN NewsFeed - 16 Oct 2006
IP Chemotherapy, Combination Therapy for Cervical Cancer and IVF Treatment for Infertility
Biopharmaceuticals Drug Delivery Oncology

HSMN NewsFeed - 21 Sep 2006
Broadlane and GENICON Introduce New Agreements Covering Endo-mechanical, Trocar, and Rigid Endoscopy Products
Devices Group Purchasing

HSMN NewsFeed - 6 Jul 2006
FDA Accepts Adeza NDA Filing for Gestiva to Prevent Preterm Births
Biopharmaceuticals FDA

HSMN NewsFeed - 27 Jun 2006
Halozyme and Baxter Announce Availability of Hylenex for Subcutaneous Delivery of Medications and Fluids
Biopharmaceuticals

HSMN NewsFeed - 23 May 2006
Halozyme Therapeutics Announces FDA 510(k) Clearance for MediCult's SynVitro Cumulase Product
Biopharmaceuticals FDA

HSMN NewsFeed - 10 May 2006
Unigene Enters into Exclusive Distribution Agreement for Fortical(R) Nasal Spray in Israel
Biopharmaceuticals Drug Delivery Distribution

HSMN NewsFeed - 9 May 2006
ETHICON, Inc. Completes Acquisition of Vascular Control Systems, Inc.
Devices Mergers & Acquisitions

HSMN NewsFeed - 8 May 2006
Cook Launches Women's Health Business Unit To Increase Quality of Life for Female Patients
Devices

Return to NewsFeed

Additional items found! 107

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 107 additional stories matching:
infertility
(Password required)

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!